S79 Lipoproteins: Not by the Numbers

Program: Symposia
Basic/Translational Session
Sunday, March 8, 2015: 2:15 PM-3:45 PM
Room 33 (San Diego Convention Center)
**This session is eligible for CME credit**

Lars Folke Berglund, M.D., Ph.D., University of California, Davis, Sacramento, CA

Nothing to Disclose: LFB
2:15 PM
Sergio Fazio, MD, PhD, Knight Cardiovascular Institute, Oregon Health and Science University, Portland, OR
Disclosure: SF: Ad Hoc Consultant, Roche Pharmaceuticals, Ad Hoc Consultant, Sanofi, Ad Hoc Consultant, Kowa, Ad Hoc Consultant, Lupin, Advisory Group Member, Merck & Co., Ad Hoc Consultant, Merck & Co., Ad Hoc Consultant, Amarin.
2:45 PM
Monty Krieger, Biology, Massachusetts Institute of Technology, Cambridge, MA
Nothing to Disclose: MK
3:15 PM
Jennifer G Robinson, MD MPH, Epidemiology, University of Iowa College of Public Health, Iowa City, IA
Disclosure: JGR: Principal Investigator, Amarin, Scientific Board Member, Amgen, Principal Investigator, Amgen, Principal Investigator, Astra Zeneca, Principal Investigator, Eisai, Principal Investigator, Eli Lilly & Company, Principal Investigator, GlaxoSmithKline, Principal Investigator, Merck & Co., Principal Investigator, Pfizer, Inc., Scientific Board Member, Pfizer, Inc., Principal Investigator, Sanofi, Scientific Board Member, Sanofi, Principal Investigator, Takeda.
See more of: Symposia